Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DESIFOR: Rosuvastatin in Statin-Intolerant Patients
NCT03889314Phase 4Unknown
- Sponsor
- Minneapolis Heart Institute Foundation
- Start
- Apr 2019
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin in hypercholesterolemia, atherosclerotic cardiovascular disease (ASCVD), sponsored by Minneapolis Heart Institute Foundation. Status: unknown.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemiaatherosclerotic cardiovascular disease (ASCVD)
Beyond the preview
Go deeper on NCT03889314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03889314.